Buteyko Breath Retraining has been verified by the AHQR, Thorax Journal and other organizations as a legitimate technique to improve the symptoms of asthma and related respiratory illness. This simple technique could be instituted for a low cost to improve the quality of life of patients, reduce medications necessary for good control and save taxpayers and insurance companies a great deal of money.
The major barrier to further reducing mortality from ACS in particular STEMI remains patient delay. Symptoms are either ignored or misinterpreted and this behavior has not changed despite community education efforts. The advance of social media as well as smartphones and other internet based tools suggests that there is a new opportunity to potentially help change human behavior.
Identifying breast cancer survivors at high risk for CV morbidity and mortality to allow targeting of management strategies to reduce CV events and thereby improve overall cancer-related survival.
Does screening for asymptomatic vascular disease increase awareness, promote compliance with lifestyle interventions, and improve overall health?
What can research institutions do to entice and support potential and actual K award applicants to become independent scientists?
Pragmatic and adequately powered clinical trials are an ongoing challenge.
Develop new tools to facilitate identification and recruitment of subjects, remote/wireless data collection, and functional measures.
Why can’t all training grants (T, K, etc) be opened out to all people working in US institutions, regardless of citizenship or green-card?
Why can’t we establish mechanisms for US junior investigators and mentors interested in global NHLBI areas?